4:08 PM
 | 
Feb 12, 2018
 |  BC Extra  |  Financial News

DiaCarta closes $45M series B

Molecular diagnostics company DiaCarta Inc. (Hayward, Calif.) said it completed a $45 million series B round. The round’s second close, announced Monday, was led by Fortune Foundation Capital with participation from Good Health Capital. The company did not respond to inquiries regarding the round’s first close.

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

Purchase this article for limited one-time distribution and website posting

$750 USD